A detailed history of Generali Investments, Management CO LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Generali Investments, Management CO LLC holds 19,874 shares of BMY stock, worth $1.1 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
19,874
Holding current value
$1.1 Million
% of portfolio
0.29%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025

BUY
$51.92 - $59.94 $1.03 Million - $1.19 Million
19,874 New
19,874 $1.12 Billion

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $118B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Generali Investments, Management CO LLC Portfolio

Follow Generali Investments, Management CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Generali Investments, Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Generali Investments, Management CO LLC with notifications on news.